Researchers at Columbia University have developed a non-invasive method to measure beta cell mass in diabetic rats using positron emission tomography (PET)-based quantitation of pancreatic radiolabeled VMAT2 receptors. This method has the potential to study the pathogenesis of diabetes and monitor therapeutic interventions.
Researchers found that the steroid and xenobiotic receptor (SXR) negatively regulates CYP24 expression and subsequent vitamin D breakdown, but can also enhance vitamin D hydroxylation and breakdown by inducing CYP3A4. Additionally, IL-15 administration restored CD4+ T cell production in an animal model of HIV infection, while lithium w...
Researchers found that SXR inhibits VDR-mediated CYP24 activity in mice, contradicting previous studies. In humans, rifampicin treatment increases CYP3A4 expression but has no effect on CYP24 expression, suggesting a complex regulatory mechanism.
Researchers found that blocking the H1 histamine receptor can effectively reduce allergic lung responses and alleviate symptoms of hay fever. The study suggests this approach could provide new treatment options for individuals suffering from allergies.
Research reveals a previously unknown role for histamine receptors in asthma, suggesting that blocking these receptors could alleviate symptoms. Additionally, a novel peptide inhibitor has been discovered to prevent bone loss in osteoporosis by targeting the RANK/TNF pathway.
Researchers discovered that prostaglandin E2 activates the pairing of EP1R with beta2AR receptors, reducing their ability to cause muscle relaxation. This may explain why some asthma treatments fail for individuals with elevated PGE2 levels.
Researchers identify EP1R as a key player in failed asthma treatments, revealing its interaction with beta2-adrenergic receptors. The discovery opens up new avenues for developing selective drugs to treat severe asthma in individuals who don't respond to current therapies.
A study found that HDL from CETP-deficient individuals promotes enhanced cholesterol efflux from macrophages through an apoE- and ABCG1-dependent pathway. This finding raises hope for using a CETP inhibitor to elevate HDL levels and reduce the incidence of atherosclerosis.
Researchers found a synergistic combination of a low-dose CD3 antibody and proinsulin peptide to reverse recent-onset type 1 diabetes in mice, promoting pancreatic beta cell regeneration. This approach may hold great potential for the treatment of individuals with recent-onset type 1 diabetes.
Researchers develop a combination therapy that reverses recent-onset type 1 diabetes in mice by inducing regulatory T cells to shield insulin-producing cells from autoimmune destruction. The therapy, which combines an oral and intranasal treatment, shows greater efficacy than individual treatments alone.
COX-2 inhibitors increase myocardial infarction and stroke risk due to suppression of prostacyclin and PGE2. Inhibiting microsomal PGE synthase-1 may offer anti-inflammatory effects without cardiovascular consequences, suggesting a potential alternative therapeutic option.
A team of researchers has identified a potential alternative therapeutic option to COX-2 inhibitors by targeting microsomal prostaglandin E synthase-1 (mPGES-1). Inhibiting mPGES-1 suppresses PGE2 expression while augmenting PGI2 production, without affecting blood clotting or blood pressure.
Researchers found that cystamine and a related drug increase levels of protective protein HSJ1b, which helps neurons survive in Huntington disease. This may lead to potential treatments for the neurodegenerative disorder.
In a study on Huntington disease, researchers found that cystamine increased brain levels of protective protein HSJ1b and BDNF, suggesting a promising candidate for treatment. The study also revealed that cystamine raises BDNF in an HSJ1b-dependent manner.
Adult stem cells can make new tendon tissue and repair damaged tendons in rats. The study demonstrates potential for using this technology to treat musculoskeletal injuries and degenerative diseases.
Researchers have successfully induced neotendon formation in mesenchymal stem cells using the Smad8 signaling pathway. This breakthrough could lead to new cell-based therapeutic approaches for musculoskeletal injuries.
A recent study published in the Journal of Clinical Investigation sheds light on the mechanism underlying microglia's behavior in multiple sclerosis. Researchers found that controlled inflammatory responses can restore damaged myelin and nerve function, suggesting a potential therapeutic target for MS treatment. Additionally, studies o...
Research findings clarify microglia's induction and blockage of oligodendrogenesis in MS, shedding light on disease mechanisms. The study highlights the complex interplay between microglial activation and oligodendrogenesis in MS.
Researchers found combining atorvastatin with glatiramer acetate significantly improved treatment outcomes for multiple sclerosis. The study showed a synergistic effect between the two medications, leading to better control of CNS autoimmunity.
Researchers found that combining immune modulating drugs can greatly reduce MS disease severity, with less myelin loss and CNS inflammation. The combination therapy utilized lower doses of each drug and promoted the secretion of anti-inflammatory molecules IL-10.
Researchers found that inhibiting an enzyme in the liver, CPT1A, improved feeding behavior and blood sugar levels in obese rats. The study suggests a biochemical pathway involved in nutrient sensing may play a critical role in diet-induced obesity and insulin resistance.
Researchers found that inhibiting CPT1A in rats improved insulin sensitivity and reduced blood sugar levels, suggesting a critical role for this enzyme in nutrient sensing. The study provides new insights into the molecular mechanisms underlying diet-induced obesity and insulin resistance.
Researchers block C5a receptor to prevent or induce asthma-like symptoms in mice, identifying mechanism by which C5aR signaling prevents response. C5aR blockade also reduces severity of asthma-like symptoms after allergen exposure.
Researchers have found that C5aR blockade promotes Th2 sensitization upon first exposure to inhaled allergen, while during established inflammation suppresses the cardinal features of asthma. This study provides new insights into the role of the anaphylatoxin C5a receptor in type 2 immunity and asthma.
Research reveals a homing mechanism for bone marrow-derived progenitor cell recruitment to neovasculature. This process is crucial in cancer progression as it enables tumors to acquire new blood vessels.
Researchers found that a protein called alpha4-beta1 integrin promotes the homing of bone marrow-derived progenitor cells to tumor-associated blood vessels. Inhibiting this process could be useful in suppressing new blood vessel formation in tumors.
Researchers have identified CXCR2 as essential for neutrophil migration into the lungs of mice exposed to lipopolysaccharide (LPS). The presence of CXCR2 on blood vessel wall cells and epithelial cells lining airways facilitates this process.
A study published in the Journal of Clinical Investigation reveals that expression of CXCR2 on blood vessel wall cells mediates neutrophil influx into the lung during acute bacterial infection. Additionally, researchers found that FoxO1 plays a critical role in regulating beta cell numbers during insulin resistance and inhibiting acety...
Research finds elastases cause emphysema through generation of pro-inflammatory elastin fragments. Blocking elastin fragment activity prevents emphysema in both mouse models. Elastin fragments are chemotactic, attracting inflammatory cells.
Researchers discovered that elastin fragments in mice lungs trigger emphysema. Additionally, a study found that pericyte dysfunction allows tumors to spread by forming leaky blood vessels. Another study identified female mice lacking IBP protein, which makes their T cells resistant to death and contributes to lupus-like disease.
A genetic mutation in a heart protein has been identified as a risk factor for sudden infant death syndrome (SIDS) in African American infants. Diabetic patients may benefit from a nerve survival protein called GDNF to treat gastrointestinal disorders related to diabetes.
Researchers identified a common cardiac sodium channel variant, SCN5A S1103Y, as a risk factor for sudden infant death syndrome (SIDS) in African Americans. The study provides new insights into the genetic causes of SIDS and highlights the importance of understanding the interplay between genetic and environmental factors.
A study published in the Journal of Clinical Investigation found a connection between cataract development and cholesterol levels. Researchers discovered that rats with specific gene mutations had lower cholesterol levels in their eyes, suggesting an abnormality in epithelial cell maturation contributing to lens opacity. This link has ...
Cataract formation is linked to cholesterol biosynthesis defects. Epithelial cells in the lens mature abnormally, leading to opacity. The study identifies a connection between cholesterol synthesis and cataract development.
A recent study has found that a specific genetic variation, ALDH2*2, is responsible for the reduced effectiveness of nitroglycerin in Asian populations. This variation affects the enzyme aldehyde dehydrogenase-2 (ALDH2), which plays a crucial role in metabolizing nitroglycerin.
Researchers have identified a new vitamin D-related compound that inhibits the production of c-Fos protein, which plays a key role in bone breakdown and resorption. In contrast, a nuclear protein called Tlx acts as an oxygen-sensing switch to regulate angiogenesis in retinal astrocytes.
Researchers have identified vitamin D as a potential target for preventing bone loss and osteoporosis. The study suggests that vitamin D may signal anti-osteoclastogenic action, which could lead to new treatments for this condition.
Research reveals that blocking the fat hormone leptin can slow disease progression and reduce symptoms in multiple sclerosis. Leptin blockade improves clinical symptoms, slows disease progression, reduces disease relapses, and decreases antigen-specific T cells.
Researchers found that leptin blockade improved clinical symptoms of disease, slowed progression, reduced relapses, and reduced antigen-specific T cells in experimental autoimmune encephalomyelitis. Additionally, the study suggests that leptin neutralization may be a potential way to treat multiple sclerosis.
Researchers found that a soy-based diet caused significant growth in the hearts of male mice, whereas female mice showed no such effect. The study suggests that phytoestrogens may play a role in exacerbating heart disease, particularly in males.
Researchers found that mice fed a soy-based diet had significantly worse heart problems than those on a milk protein-based diet. This is the first study to show an environmental influence can affect the heart.
A study published in JCI Journal reveals that alpha-basic-crystallin is overexpressed in breast cancer tumors and triggers tumor development. The protein causes dysregulated growth, changes in cell structure, and diminished programmed cell death, ultimately leading to poor clinical outcomes.
Researchers discovered that macrophages secreting a specific enzyme trigger the rupture of unstable plaques in arteries, leading to cardiovascular events. The study suggests targeting this enzyme may help stabilize precarious plaques and reduce the risk of heart attacks and strokes.
Researchers found that expressing active MMP-9 in macrophages within atherosclerotic plaques leads to their rupture, causing blood clots and reduced blood flow. Additionally, the inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.
Researchers have developed a strategy to deliver PDGF-BB to the infarcted heart using injectable self-assembling peptide nanofibers, protecting cardiomyocytes from death and preserving cardiac function. The therapy reduced infarct size and improved cardiac function in rats.
Researchers developed a strategy to deliver PDGF-BB to cardiomyocytes using self-assembling peptide nanofibers, protecting them from injury and reducing infarct size. This approach holds promise for tissue regeneration after cardiac injury.
Researchers have successfully treated hereditary spastic paraplegia by delivering a normal paraplegin protein to spinal motor neurons via gene therapy. This approach improved motor function in mice and holds promise for treating other forms of peripheral nerve damage caused by genetic mutations.
Researchers have found that a specific immunization strategy targeting Abeta42 or Abeta40 can prevent amyloid deposition in mice, suggesting an effective approach for preventing Alzheimer's disease. However, this method may not be effective once existing deposits are established.
Researchers discover that preventing amyloid deposition may be easier than curing established Alzheimer's disease through an immunization strategy targeting Abeta42. Additionally, a study finds that pre-treatment of patient T cells with IL-10 and vitamin D3 can overcome glucocorticoid resistance in asthma patients.
Researchers discovered that nicotinic acid activates GPR109A on fat cells to lower lipid levels, but on immune cells in the skin, it triggers flushing responses. This study supports the hypothesis that immune cells are a primary source of arachidonic acid and prostaglandins causing hot flashes.